| Contemporary epidemiology of chronic liver disease and cirrhosis AM Moon, AG Singal, EB Tapper Clinical Gastroenterology and Hepatology 18 (12), 2650-2666, 2020 | 1064 | 2020 |
| Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021 AF Peery, SD Crockett, CC Murphy, ET Jensen, HP Kim, MD Egberg, ... Gastroenterology 162 (2), 621-644, 2022 | 558 | 2022 |
| Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ... Journal of hepatology 74 (3), 567-577, 2021 | 540 | 2021 |
| COVID-19 and liver disease: mechanistic and clinical perspectives T Marjot, GJ Webb, AS Barritt IV, AM Moon, Z Stamataki, VW Wong, ... Nature reviews Gastroenterology & hepatology 18 (5), 348-364, 2021 | 407 | 2021 |
| High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry AM Moon, GJ Webb, C Aloman, MJ Armstrong, T Cargill, R Dhanasekaran, ... Journal of hepatology 73 (3), 705, 2020 | 326 | 2020 |
| Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ... The lancet Gastroenterology & hepatology 5 (11), 1008-1016, 2020 | 261 | 2020 |
| FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 T Brevini, M Maes, GJ Webb, BV John, CD Fuchs, G Buescher, L Wang, ... Nature 615 (7950), 134-142, 2023 | 230 | 2023 |
| Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation AM Moon, B Curtis, P Mandrekar, AK Singal, EC Verna, OK Fix Hepatology communications 5 (9), 1616-1621, 2021 | 136 | 2021 |
| SARS-CoV-2 infection in patients with autoimmune hepatitis T Marjot, G Buescher, M Sebode, E Barnes, AS Barritt IV, MJ Armstrong, ... Journal of hepatology 74 (6), 1335-1343, 2021 | 119 | 2021 |
| Determining risk factors for mortality in liver transplant patients with COVID-19 GJ Webb, AM Moon, E Barnes, AS Barritt, T Marjot The lancet. Gastroenterology & hepatology 5 (7), 643, 2020 | 109 | 2020 |
| No association between screening for hepatocellular carcinoma and reduced cancer-related mortality in patients with cirrhosis AM Moon, NS Weiss, LA Beste, F Su, SB Ho, GY Jin, E Lowy, K Berry, ... Gastroenterology 155 (4), 1128-1139. e6, 2018 | 108 | 2018 |
| Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing‐remitting multiple sclerosis Y Li, V Jewells, M Kim, Y Chen, A Moon, D Armao, L Troiani, ... Human brain mapping 34 (12), 3376-3391, 2013 | 106 | 2013 |
| The psychological harms of screening: the evidence we have versus the evidence we need JT DeFrank, C Barclay, S Sheridan, NT Brewer, M Gilliam, AM Moon, ... Journal of general internal medicine 30, 242-248, 2015 | 80 | 2015 |
| Impact of exposure to patients with COVID-19 on residents and fellows: an international survey of 1420 trainees AL Cravero, NJ Kim, LD Feld, K Berry, A Rabiee, N Bazarbashi, S Bassin, ... Postgraduate medical journal 97 (1153), 706-715, 2021 | 70 | 2021 |
| Rising mortality from alcohol-associated liver disease in the United States in the 21st century AM Moon, JY Yang, AS Barritt IV, R Bataller, AF Peery Official journal of the American College of Gastroenterology| ACG 115 (1), 79-87, 2020 | 69 | 2020 |
| SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question T Marjot, GJ Webb, AS Barritt, P Ginès, AW Lohse, AM Moon, E Pose, ... The lancet. Gastroenterology & hepatology 6 (3), 156, 2021 | 62 | 2021 |
| Alcohol-associated liver disease mortality increased from 2017 to 2020 and accelerated during the COVID-19 pandemic S Deutsch-Link, Y Jiang, AF Peery, AS Barritt, R Bataller, AM Moon Clinical Gastroenterology and Hepatology 20 (9), 2142-2144. e2, 2022 | 59 | 2022 |
| Elevated liver enzymes in patients with COVID-19: look, but not too hard AM Moon, AS Barritt Digestive Diseases and Sciences 66, 1767-1769, 2021 | 57 | 2021 |
| Successful treatment of cannabinoid hyperemesis syndrome with topical capsaicin AM Moon, SA Buckley, NM Mark ACG case reports journal 5 (1), e3, 2018 | 53 | 2018 |
| Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents AM Moon, PK Green, K Berry, GN Ioannou Alimentary pharmacology & therapeutics 45 (9), 1201-1212, 2017 | 53 | 2017 |